Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial
Authors
Suzanne Trudel•Nikoletta Lendvai•Adam Cohen
Journal
The Lancet Oncology
Published
November 13, 2018
Sign in to comment
Add a comment...
Supporters
Support the authors with ResearchCoin
Topics
DOI
License
publisher-specific-oa
No comments yet. Start the conversation!
Your contribution could help open science.